“A drug that treats tumors and epilepsy in people with tuberous sclerosis complex does not…” Continue reading.
This news story originally appeared in the September 9, 2019 issue of This Week in the News. This Week in the News contains summaries of recent news stories relevant to speech-language pathology and audiology, including published research studies, opinion pieces and personal stories. In sharing this news with you, we aim to keep you informed of conversations pertinent to the professions as they happen around the world. The opinions expressed in these stories do not necessarily represent the views of Speech-Language & Audiology Canada, nor does our inclusion of a story indicate our endorsement of the article’s viewpoint or accuracy.